SI c.3562G>C ;(p.V1188L)

Variant ID: 3-164735620-C-G

NM_001041.3(SI):c.3562G>C;(p.V1188L)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase.

Therapeutic Advances In Medical Oncology
Yao, Hang-Ping HP; Tong, Xiang-Min XM; Wang, Ming-Hai MH
Publication Date: 2021

Variant appearance in text: SI: V1188L
PubMed Link: 33868463
Variant Present in the following documents:
  • 10.1177_17588359211006957.pdf
View BVdb publication page